Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://tayakxie471689.ltfblog.com/37578138/trelaglutide-exploring-a-new-option-for-chronic-diseases